Leading Market Players:

 Taxus Cardium (US), ViroMed Co. Ltd. (Republic of Korea ), Edward Lifesciences (US), Daiichi Sankyo Company Limited (Japan), Boston Scientific Corporation (US), Merck KGaA (Germany), Novartis AG (Switzerland), Boehringer Ingelheim International GmbH (Germany), Johnson & Johnson Services Inc. (US), Bayer AG (Germany), and AstraZeneca (UK).

Pick up the FREE SAMPLE Copy @ https://www.marketresearchfuture.com/sample_request/5811

Myocardial Ischemia Market Overview:

The causes of myocardial ischemia, such as physical inactivity, high cholesterol, diabetes, etc., is inevitably deep-rooted in the changing lifestyle of the population across the world and is fueling the market growth. The recent report published by Market Research Future (MRFR) reveals the global myocardial ischemia market will exhibit robust growth at 6.1% CAGR from 2017 to 2023.

Table of Content

4              Market Dynamics           

4.1          Introduction      

4.2          Driver

4.2.1      High Prevalence of Coronary Heart Disease         

4.2.2      Rising Prevalence of Diabetes    

4.2.3      Lifestyle Changes            

4.2.4      Drivers Impact Analysis 

4.3          Restraints           

4.3.1      High Cost of Therapeutic Surgeries          

4.3.2      Side Effects Related to Medications        

4.3.3      Restraints Impact Analysis           

4.4          Opportunity      

4.4.1      Untapped markets of the Asia-Pacific region       

4.5          Macroeconomic Indicator            

5              Market Factor Analysis

5.1          Value Chain Analysis      

5.1.1      R&D and Designing         

5.1.2      Manufacturing 

5.1.3      Distribution & Sales       

5.1.4      Post-Sales Review          

5.2          Porter’s Five Forces Model          

5.2.1      Bargaining Power of Suppliers   

5.2.2      Bargaining Power of Buyers        

5.2.3      Threat of New Entrants

5.2.4      Threat of Substitutes     

5.2.5      Intensity of Rivalry          

5.3          Investment Opportunities           

5.4          Pricing Analysis

5.5          Demand & Supply: Gap Analysis

Continued…

List of Tables

TABLE 1                GLOBAL MYOCARDIAL ISCHEMIA MARKET: BY TYPE 2015-2023 (USD MILLION)   

TABLE 2                GLOBAL MYOCARDIAL ISCHEMIA MARKET: FOR SYMPTOMATIC TYPE 2015-2023 (USD MILLION)

TABLE 3                GLOBAL MYOCARDIAL ISCHEMIA MARKET: FOR ASYMPTOMATIC TYPE 2015-2023 (USD MILLION)

TABLE 4               GLOBAL MYOCARDIAL ISCHEMIA MARKET: BY TREATMENT & DIAGNOSIS 2015-2023 (USD  MILLION)                       

TABLE 5                GLOBAL MYOCARDIAL ISCHEMIA MARKET: BY DIAGNOSIS TYPE 2015-2023 (USD MILLION)            

Continued…

List of Figures

FIGURE 1              MARKET STRUCTURE     

FIGURE 2              RESEARCH PROCESS       

FIGURE 3              DROC ANALYSIS OF GLOBAL MYOCARDIAL ISCHEMIA MARKET

FIGURE 4              DRIVERS IMPACT ANALYSIS: GLOBAL MYOCARDIAL ISCHEMIA MARKET   

FIGURE 5              RESTRAINTS IMPACT ANALYSIS: GLOBAL MYOCARDIAL ISCHEMIA MARKET

Continued…

Global Market for Myocardial Ischemia – Segmental Analysis

By type, the market is segmented on the basis of symptomatic and asymptomatic. The asymptomatic (silent) myocardial ischemia segment accounted for the largest market share in 2017. Growing number of smokers, family history of heart diseases, prevalence of cases of high cholesterol and high blood pressure, and lack of exercise can drive the growth in the segment.

By treatment & diagnosis, the market is segmented into treatment and diagnosis. The diagnosis segment is sub-segmented into imaging and stress test. On the other hand, the treatment segment is sub-segmented into medications and surgery. The treatment segment has gained significant traction owing to increasing prevalence of coronary heart disease and large population leading a stressful lifestyle.

The end-users, hospitals & clinics, diagnostic centers, ambulatory surgery centers, and others.

Market Research Future (MRFR) publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit @ https://www.marketresearchfuture.com/reports/myocardial-ischemia-market-5811

AstraZeneca will expand its Global Medicines Development (GMD) unit in Bengaluru, India. The site which will be inaugurated is one of the nine global sites that will support clinical trials, monitor safety, efficacy and other regulatory management required during a product’s lifecycle. The center will support India as well as the work done globally by the organization.

Browse Other Healthcare Related Reports

Clinical Laboratory Services Market Research Report – Global Forecast till 2023

Multiple Sclerosis Treatment Market Research Report – Global Forecast till 2023

About Market Research Future:

MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: www.marketresearchfuture.com/reports/myocardial-ischemia-market-5811